Open Access iconOpen Access

ARTICLE

Development of a prognostic signature for esophageal cancer based on a novel 7-DNA damage repair genes signature

JIAMING ZHAN, WEIHUA WANG, YANLEI TANG, NING ZHOU, DAOWEN JIANG*

Department of Thoracic Surgery, Minhang Hospital, Fudan University, Shanghai, 201199, China

* Corresponding Author: DAOWEN JIANG. Email: email

(This article belongs to the Special Issue: )

BIOCELL 2022, 46(12), 2601-2613. https://doi.org/10.32604/biocell.2022.021300

Abstract

Esophageal cancer (EC) was an aggressive malignant neoplasm characterized by high morbidity and poor prognosis. Identifying the changes in DNA damage repair genes helps to better understand the mechanisms of carcinoma progression. In this study, by comparing EC samples and normal samples, we found a total of 132 DDR expression with a significant difference. Moreover, we revealed higher expression of POLN, PALB2, ATM, PER1, TOP3B and lower expression of HMGB1, UBE2B were correlated to longer OS in EC. In addition, a prognostic risk score based on 7 DDR gene expression (POLN, HMGB1, TOP3B, PER1, UBE2B, ATM, PALB2) was constructed for the prognosis of EC. Meanwhile, EC cancer samples were divided into 3 subtypes based on 132 DDR genes expressions. Clinical profile analysis showed cluster C1 and C2 showed a similar frequency of T2, which was remarked higher than that in cluster 3. Moreover, we found the immune cell inflation levels were significantly changed in different subtypes of EC. The infiltration levels of T cell CD8+, B cell and NK cells were greatly higher in cluster 2 than that in cluster 1 and cluster 3. The results showed T cell CD4+ infiltration levels were dramatically higher in cluster 1 than that in cluster 2 and cluster 3. Finally, we perform bioinformatics analysis of DEGs among 3 subtypes of EC and found DDR genes may be related to multiple signaling, such as Base excision repair, Cell cycle, Hedgehog signaling pathway, and Glycolysis/Gluconeogenesis. These results showed DDR genes may serve as new target for the prognosis of EC and prediction of the potential response of immune therapy in EC.

Keywords


Cite This Article

APA Style
ZHAN, J., WANG, W., TANG, Y., ZHOU, N., JIANG, D. (2022). Development of a prognostic signature for esophageal cancer based on a novel 7-DNA damage repair genes signature. BIOCELL, 46(12), 2601-2613. https://doi.org/10.32604/biocell.2022.021300
Vancouver Style
ZHAN J, WANG W, TANG Y, ZHOU N, JIANG D. Development of a prognostic signature for esophageal cancer based on a novel 7-DNA damage repair genes signature. BIOCELL . 2022;46(12):2601-2613 https://doi.org/10.32604/biocell.2022.021300
IEEE Style
J. ZHAN, W. WANG, Y. TANG, N. ZHOU, and D. JIANG "Development of a prognostic signature for esophageal cancer based on a novel 7-DNA damage repair genes signature," BIOCELL , vol. 46, no. 12, pp. 2601-2613. 2022. https://doi.org/10.32604/biocell.2022.021300



cc This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 900

    View

  • 580

    Download

  • 0

    Like

Share Link